Matthew Dean Brovold, PhD

Matthew Dean Brovold, PhD has a diverse work experience in various research and management roles. Matthew Dean is currently working as the Science and Funding Manager at BRINTER since March 2023. Previously, from 2021 to March 2023, they served as the Tissue Team Research Manager at ReMDO, where they managed technical collaborations with academic and industry partners. Before that, from 2020 to March 2023, they worked as a Postdoctoral Researcher at the Wake Forest Institute for Regenerative Medicine, leading a team in developing a printable universal bioink for 3D cell culture. Starting from 2013 to 2020, they were a Graduate Researcher at Wake Forest University, focusing on liver bioengineering and the development of bioengineered 3D organoids. Prior to that, from 2011 to 2013, they worked as a Research Technologist and Research Assistant at Arizona State University, where they were involved in a project related to engineered self-destructing Salmonella as a potential colorectal cancer cure. Additionally, they have experience as a Property Manager at W.D. Schock Compay inc. from 2006 to 2009.

Matthew Dean Brovold, PhD began their education journey in 2009 at Arizona State University, where they pursued a Bachelor of Science (BS) in Genetics, Cellular and Developmental Biology. Matthew Dean successfully completed this program in 2011. In 2013, they enrolled in Wake Forest University, where they dedicated himself to pursuing a Doctor of Philosophy (PhD). Matthew completed their PhD in 2020 with a specialization that is not specified.